The global mobile cardiac telemetry devices market reached USD 459.1 Million in 2017 by registering a CAGR of 12.4% across the globe. Moreover, the market is expected to garner USD 1,470.7 Million by the end of 2027.
The global demand for mobile cardiac telemetry devices is increasing due to massive growth of healthcare industry across the globe. Further, increasing awareness about cardiac diseases and rising incidence of cardiovascular diseases is a key growth driver for global mobile cardiac telemetry devices market.
North America is slated to account for a share of 40.7% by 2027 in the mobile cardiac telemetry devices market. The growth in the region can be attributed to growing prevalence in the number of cardiac deaths. Increasing technological innovations in mobile cardiac telemetry devices is also expected to impel the growth of mobile cardiac telemetry devices market in the North America. U.S. is the prominent market driving the growth in the region.
Europe market is expected to expand at highest CAGR of 12.5% during the forecast period i.e. 2018-2027. Europe mobile cardiac telemetry devices market is projected to reach to a valuation of USD 444.1 Million by the end of 2027 from USD 137.7 Million in 2017. Europe mobile cardiac telemetry devices market is expected to mark 12.8% growth rate in 2027. Germany is the prominent market driving the growth in the region.
Global mobile cardiac telemetry devices market is segmented on the basis of technology into lead based and patch based. Among these segments, lead based segment (60.7% share in 2017) occupies the largest market of mobile cardiac telemetry devices across the globe. Further, global lead based segment is anticipated to reach USD 879.0 Million by the end of 2027 from USD 278.8 Million in 2017. Moreover, this segment is anticipated to flourish at a CAGR of 12.2% over the forecast period. In addition, patch based segment of mobile cardiac telemetry devices is expected to achieve Y-o-Y growth rate of 13.0% in 2027 as compared to previous year.
In addition this, global mobile cardiac telemetry devices market is also segmented by end-user. In end-user segment, the hospitals segment is estimated to remain highest during the forecast period. This segment contributed around 61.0% market share of total mobile cardiac telemetry devices market in 2017. Further, this segment is projected to capture 59.9% market share by 2027. Further, hospitals segment is projected to achieve Y-o-Y growth rate of 12.5% in 2027 as compared to previous year.
BioTelemetry Inc., Medicomp Inc. , Welch Allyn, Preventice Solutions, ScottCare and Applied Cardiac Systems Inc. are some of the prominent players of mobile cardiac telemetry devices market.
The global demand for mobile cardiac telemetry devices is increasing due to massive growth of healthcare industry across the globe. Further, increasing awareness about cardiac diseases and rising incidence of cardiovascular diseases is a key growth driver for global mobile cardiac telemetry devices market.
North America is slated to account for a share of 40.7% by 2027 in the mobile cardiac telemetry devices market. The growth in the region can be attributed to growing prevalence in the number of cardiac deaths. Increasing technological innovations in mobile cardiac telemetry devices is also expected to impel the growth of mobile cardiac telemetry devices market in the North America. U.S. is the prominent market driving the growth in the region.
Europe market is expected to expand at highest CAGR of 12.5% during the forecast period i.e. 2018-2027. Europe mobile cardiac telemetry devices market is projected to reach to a valuation of USD 444.1 Million by the end of 2027 from USD 137.7 Million in 2017. Europe mobile cardiac telemetry devices market is expected to mark 12.8% growth rate in 2027. Germany is the prominent market driving the growth in the region.
Global mobile cardiac telemetry devices market is segmented on the basis of technology into lead based and patch based. Among these segments, lead based segment (60.7% share in 2017) occupies the largest market of mobile cardiac telemetry devices across the globe. Further, global lead based segment is anticipated to reach USD 879.0 Million by the end of 2027 from USD 278.8 Million in 2017. Moreover, this segment is anticipated to flourish at a CAGR of 12.2% over the forecast period. In addition, patch based segment of mobile cardiac telemetry devices is expected to achieve Y-o-Y growth rate of 13.0% in 2027 as compared to previous year.
In addition this, global mobile cardiac telemetry devices market is also segmented by end-user. In end-user segment, the hospitals segment is estimated to remain highest during the forecast period. This segment contributed around 61.0% market share of total mobile cardiac telemetry devices market in 2017. Further, this segment is projected to capture 59.9% market share by 2027. Further, hospitals segment is projected to achieve Y-o-Y growth rate of 12.5% in 2027 as compared to previous year.
BioTelemetry Inc., Medicomp Inc. , Welch Allyn, Preventice Solutions, ScottCare and Applied Cardiac Systems Inc. are some of the prominent players of mobile cardiac telemetry devices market.
Table of Contents
1. Research Methodology2. Market Definitions, Assumptions & Abbreviations3. Market Taxonomy4. Global Mobile Cardiac Telemetry Devices Market - Executive Summary
5. Mobile Cardiac Telemetry Devices Product Overview
11. Mobile Cardiac Telemetry Devices Market - Risk Analysis
12. Market Dynamics & Its Impact Analysis
14. Global Mobile Cardiac Telemetry Devices Market Segmentation Analysis By Technology
15. Global Mobile Cardiac Telemetry Devices Market Segmentation Analysis By End User
16. Global Mobile Cardiac Telemetry Devices Market Segmentation Analysis By Geography
17. Competitive Landscape
Companies Mentioned
- BioTelemetry Inc.
- Medicomp
- Preventice
- Scottcare
- Welch Allyn
- Applied Cardiac Systems
- ZOLL Medical
- Biotricity
- National Cardiac
- Telerhythmics